Biozen, LLC, today announced it will present prospective clinical validation data for its cuffless blood pressure technology at the American College of Cardiology (ACC) Scientific Sessions, taking ...
LONDON, UNITED KINGDOM, May 1, 2025 /EINPresswire.com/ -- BioZen Limited, a clinical-stage biotech company focussed on developing innovative treatments for endocrine ...
Funding from our first institutional investor for both clinical trials is another strong endorsement of BioZen's approach and the large unmet medical need With support from Syneos Health and now ...
One of four companies selected to present at the American College of Cardiology Scientific Sessions in New Orleans OKLAHOMA CITY, March 26, 2026 /PRNewswire/ -- Biozen, LLC has been selected as a ...
OKLAHOMA CITY, March 24, 2026 /PRNewswire/ -- Biozen, LLC, today announced it will present prospective clinical validation data for its cuffless blood pressure technology at the American College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results